In 1992, Dr. Ian Smith opened the first dedicated clinical trial centre in Europe and the Synexus story began. Today, 24 years later, we still live and work by the values of our founder.
From the outset, Synexus placed the patient at the heart of its operation, recognising the efficiencies that would come from dedicated sites and focused patient recruitment. We pioneered TV advertising to recruit for clinical trials.
Today Synexus is the world’s leading SMO, with an established network of gold standard Dedicated Synexus Research sites. At any one time Synexus is involved with over 200 clinical trials and we have a growing and thriving Synexus patient community. Throughout, our company values ensure that patients are cared for to underpin our excellent performance and ensure we continue to be the patient’s choice for clinical research.
- Patient engagement
- Customer service